• Fund Type: Unit Trust
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

AXA Framlington Biotech Fund

+ Add to Watchlist

FRABIOA:LN

144.60 GBp 1.80 1.26%

As of 00:59:30 ET on 11/27/2014.

Snapshot for AXA Framlington Biotech Fund (FRABIOA)

Year To Date: +41.26% 3-Month: +15.96% 3-Year: +45.93% 52-Week Range: 95.62 - 144.60
1-Month: +7.99% 1-Year: +41.81% 5-Year: +28.88% Beta vs NBI: 0.93

Mutual Fund Chart for FRABIOA

No chart data available.
  • FRABIOA:LN 144.60
  • 1M
  • 1Y
Interactive FRABIOA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FRABIOA

AXA Framlington Biotech Fund is an authorized unit trust incorporated in the United Kingdom. The aim of the Fund is to provide long-term capital appreciation The Fund will invest principally in equity securities of companies in the biotechnology, genomic and medical research industries worldwide.

Inception Date: 11-26-2001 Telephone: 44-207-374-4100
Managers: LINDEN THOMSON / GEMMA GAME
Web Site: www.axa-framlington.com

Fundamentals for FRABIOA

NAV (on 2014-11-27) 144.60
Assets (M) (on 2014-11-06) 429.44
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment 100.00

Dividends for FRABIOA

Dividend Type Omitted
Dividend Frequency Semi-Anl
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for FRABIOA

Front Load 5.50
Back Load 0.00
Current Mgmt Fee 1.75
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 1.95

Top Fund Holdings for FRABIOA

Filing Date: 10/31/2014
Name Position Value % of Total
Celgene Corp 618,528 41,414,400 9.600%
Amgen Inc 397,172 40,120,200 9.300%
Gilead Sciences Inc 455,880 31,923,600 7.400%
Biogen Idec Inc 137,532 27,609,600 6.400%
Vertex Pharmaceuticals Inc 318,528 22,432,800 5.200%
Illumina Inc 164,810 19,844,400 4.600%
Regeneron Pharmaceuticals Inc 78,861 19,413,000 4.500%
Alexion Pharmaceuticals Inc 147,833 17,687,400 4.100%
BioMarin Pharmaceutical Inc 292,719 15,099,000 3.500%
Incyte Corp 318,959 13,373,400 3.100%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil